A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (PZ586).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples